<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Determination of Regulatory Review Period for Purposes of Patent Extension; ORGOVYX</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <style>
        body { font-family: Arial, sans-serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { color: #333; }
        .metadata { color: #666; font-size: 0.9em; }
        .summary { margin-top: 20px; line-height: 1.5; }
        .source { margin-top: 20px; }
    </style>
</head>
<body>
    <h1>Determination of Regulatory Review Period for Purposes of Patent Extension; ORGOVYX</h1>
    <div class="metadata">Published: 2026-02-05 12:48:02</div>
    <div class="summary">The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for Orgovyx and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of patents which claims that human drug product.</div>
    <div class="source">Source: <a href="https://www.federalregister.gov/documents/2023/11/29/2023-26258/determination-of-regulatory-review-period-for-purposes-of-patent-extension-orgovyx" target="_blank" rel="noopener noreferrer">https://www.federalregister.gov/documents/2023/11/29/2023-26258/determination-of-regulatory-review-period-for-purposes-of-patent-extension-orgovyx</a></div>
</body>
</html>
